Literature DB >> 2473858

The acute phase nature of interleukin 6: studies in Kawasaki disease and other febrile illnesses.

Y Ueno1, N Takano, H Kanegane, T Yokoi, A Yachie, T Miyawaki, N Taniguchi.   

Abstract

Interleukin 6 (IL-6) has manifold biological functions involved in the immune or inflammatory responses of the host to various stimuli. Here we asked whether IL-6 might be responsible for manifestations of Kawasaki disease (KD), such as immunoglobulin hypersecretion, lymphocyte activation and systemic vasculitis. IL-6 activity in the serum was determined by a sensitive colorimetric assay using an IL-6-dependent murine hybridoma clone. Usually sera from healthy or afebrile donors contained only negligible levels of IL-6 activity below the detection threshold of the assay. Importantly it was found that serum IL-6 was markedly elevated in all patients with acute KD. Serum levels of IL-6 activity gradually diminished during the course of the disease and reached undetectable or lower levels at the convalescent phase. However, such elevated levels of serum IL-6 activity were also observed in the majority of other febrile diseases, such as bacterial or viral infections, indicating that the appearance of IL-6 in the serum could generally occur in febrile or inflammatory disease conditions. Serum IL-6 activity correlated with serum concentrations of some acute phase proteins (APP), such as C-reactive protein, haptoglobin and alpha 1-acid glycoprotein, implying its role for modulating induction of APP in vivo. IL-6 is well known to be secreted by a variety of cell types. Further studies, including immunohistochemical analysis using anti-IL-6 antibody, will be necessary to examine whether the source of serum IL-6 in KD might be different from that seen in other diseases.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2473858      PMCID: PMC1541885     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  28 in total

Review 1.  Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities.

Authors:  J Le; J Vilcek
Journal:  Lab Invest       Date:  1987-03       Impact factor: 5.662

2.  Immunopathology of the skin lesion of Kawasaki disease.

Authors:  T Sugawara; S Hattori; S Hirose; S Furukawa; K Yabuta; T Shirai
Journal:  Prog Clin Biol Res       Date:  1987

Review 3.  Molecular regulation of B lymphocyte response.

Authors:  T Kishimoto; T Hirano
Journal:  Annu Rev Immunol       Date:  1988       Impact factor: 28.527

4.  Serum levels of interleukin-6 and acute phase responses.

Authors:  M W Nijsten; E R de Groot; H J ten Duis; H J Klasen; C E Hack; L A Aarden
Journal:  Lancet       Date:  1987-10-17       Impact factor: 79.321

5.  Elevated levels of the 26K human hybridoma growth factor (interleukin 6) in cerebrospinal fluid of patients with acute infection of the central nervous system.

Authors:  F A Houssiau; K Bukasa; C J Sindic; J Van Damme; J Van Snick
Journal:  Clin Exp Immunol       Date:  1988-02       Impact factor: 4.330

6.  Establishment of an interleukin 6 (IL 6)/B cell stimulatory factor 2-dependent cell line and preparation of anti-IL 6 monoclonal antibodies.

Authors:  T Matsuda; T Hirano; T Kishimoto
Journal:  Eur J Immunol       Date:  1988-06       Impact factor: 5.532

7.  Synthesis and secretion of multiple forms of beta 2-interferon/B-cell differentiation factor 2/hepatocyte-stimulating factor by human fibroblasts and monocytes.

Authors:  L T May; J Ghrayeb; U Santhanam; S B Tatter; Z Sthoeger; D C Helfgott; N Chiorazzi; G Grieninger; P B Sehgal
Journal:  J Biol Chem       Date:  1988-06-05       Impact factor: 5.157

8.  Interleukin 6 (IL-6) in serum and urine of renal transplant recipients.

Authors:  M H Van Oers; A A Van der Heyden; L A Aarden
Journal:  Clin Exp Immunol       Date:  1988-02       Impact factor: 4.330

9.  Recombinant human interleukin-6 (IL-6/BSF-2/HSF) regulates the synthesis of acute phase proteins in human hepatocytes.

Authors:  J V Castell; M J Gómez-Lechón; M David; T Hirano; T Kishimoto; P C Heinrich
Journal:  FEBS Lett       Date:  1988-05-23       Impact factor: 4.124

10.  Induction of rat acute-phase proteins by interleukin 6 in vivo.

Authors:  T Geiger; T Andus; J Klapproth; T Hirano; T Kishimoto; P C Heinrich
Journal:  Eur J Immunol       Date:  1988-05       Impact factor: 5.532

View more
  43 in total

1.  Kawasaki disease in a patient with Wiskott-Aldrich syndrome: an increase in the platelet count.

Authors:  Chihiro Kawakami; Munenori Miyake; Hiroshi Tamai
Journal:  Int J Hematol       Date:  2003-02       Impact factor: 2.490

Review 2.  Intravenous immunoglobulin therapy in vasculitis: speculation or evidence?

Authors:  Peer Malte Aries; Bernhard Hellmich; Wolfgang Ludwig Gross
Journal:  Clin Rev Allergy Immunol       Date:  2005-12       Impact factor: 8.667

3.  Polymorphisms in chemokine receptor genes and susceptibility to Kawasaki disease.

Authors:  W B Breunis; M H Biezeveld; J Geissler; I M Kuipers; J Lam; J Ottenkamp; A Hutchinson; R Welch; S J Chanock; T W Kuijpers
Journal:  Clin Exp Immunol       Date:  2007-08-02       Impact factor: 4.330

Review 4.  The immunoregulatory effects of IVIG in Kawasaki disease and other autoimmune diseases.

Authors:  D Y Leung
Journal:  Clin Rev Allergy       Date:  1992 Spring-Summer

5.  Serum soluble CD4 and CD8 levels in Kawasaki disease.

Authors:  S Furukawa; T Matsubara; K Tsuji; T Motohashi; K Okumura; K Yabuta
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

6.  Kawasaki disease differs from anaphylactoid purpura and measles with regard to tumour necrosis factor-alpha and interleukin 6 in serum.

Authors:  S Furukawa; T Matsubara; K Yone; Y Hirano; K Okumura; K Yabuta
Journal:  Eur J Pediatr       Date:  1992-01       Impact factor: 3.183

Review 7.  Kawasaki syndrome: lessons for Britain.

Authors:  J G Bissenden; S Hall
Journal:  BMJ       Date:  1990-04-21

8.  Epstein-Barr virus-immortalized B cells produce IL-6 as an autocrine growth factor.

Authors:  T Yokoi; T Miyawaki; A Yachie; K Kato; Y Kasahara; N Taniguchi
Journal:  Immunology       Date:  1990-05       Impact factor: 7.397

9.  Cytokines predict coronary aneurysm formation in Kawasaki disease patients.

Authors:  C Y Lin; C C Lin; B Hwang; B N Chiang
Journal:  Eur J Pediatr       Date:  1993-04       Impact factor: 3.183

10.  Defective production of interleukin-6 in very small premature infants in response to bacterial pathogens.

Authors:  A Yachie; N Takano; K Ohta; T Uehara; S Fujita; T Miyawaki; N Taniguchi
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.